BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alzamzamy A, Elsayed H, Abd Elraouf M, Eltoukhy H, Megahed T, Aboubakr A. Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients. World J Gastrointest Oncol 2021; 13(6): 600-611 [PMID: 34163576 DOI: 10.4251/wjgo.v13.i6.600]
URL: https://www.wjgnet.com/1948-5204/full/v13/i6/600.htm
Number Citing Articles
1
Liming Zheng, Zeyu Huang, Xiaoping Li, Meifang He, Xiaoqin Liu, Guojun Zheng, Xike Zhou, Longgen Liu. Construction and validation of a predictive model for hepatocellular carcinoma based on serum markersBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02489-2
2
Moe Matsumoto, Hidenao Noritake, Maho Yamashita, Tomohiko Hanaoka, Masahiro Umemura, Kensuke Kitsugi, Shingo Takatori, Kazuyoshi Ohta, Jun Ito, Takeshi Chida, Kazuhito Kawata. A case of hepatitis B virus-infected patient with bevacizumab-related severe intratumor hemorrhage of large hepatocellular carcinoma (HCC)Kanzo 2023; 64(8): 382 doi: 10.2957/kanzo.64.382
3
Deniz Can Guven, Enes Erul, Taha Koray Sahin, Omer Dizdar, Suayib Yalcin, Ibrahim Halil Sahin. The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysisFuture Oncology 2022; 18(37): 4119 doi: 10.2217/fon-2022-0642
4
Bing-yao Pang, Yan Leng, Xiaoli Wang, Yi-qiang Wang, Li-hong Jiang. A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinomaAnnals of Medicine 2023; 55(1): 42 doi: 10.1080/07853890.2022.2153163